search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Sequencing


define a single research object that combines all of the computational steps and their parameters (using the CWL), as well as all of the input, inter- mediate and output data, into a single object that can be referenced by a unique accession identifier. Reproducible analysis frameworks could create these BCOs for submission to regulatory agen- cies, and they could be re-executed in a different environment to reproduce the analysis from start to finish.


Technology service providers There is now a thriving market for solutions to the technical infrastructure needs of NGS practition- ers, specifically including those working in regulat- ed environments. The volumes of data generated are huge and the computational burdens are simi- larly large, and often transient. NGS analysis envi- ronments must accommodate large-scale data transfer and storage, metadata management, workflow management, data provenance, data


archiving and access to public databases. This must all be provided in an environment that supports data encryption and security, access control and auditing and data centre management according to standards such as ISO27001/27002. Furthermore, it must be easily scalable in order to handle the next project or batch of samples, but without the high overhead of a fixed infrastructure that sits idle between projects.


All of these characteristics point naturally to host- ed Platform-as-a-Service (PaaS) or Software-as-a- Service (SaaS) solutions. Companies such as DNAnexus, Bluebee and Seven Bridges Genomics provide NGS-tailored PaaS/SaaS environments built on existing infrastructure providers such as Amazon Web Services, Microsoft Azure or Google Cloud. They provide ready access to the tools and databases typically used for NGS analyses and allow customi- sation, sharing and reuse of genomic analysis pipelines. These providers can also help manage data localisation, where particular countries or


33rd


International Exhibition for Fine and Speciality Chemicals


The industry’s premier sourcing and networking event


Some 400 international exhibitors off er bespoke solutions and specifi c substances to enhance


products or develop new chemical solutions.


Fine and speciality chemicals for various industries:


pharmaceuticals • agrochemicals • petrochemicals • cosmetics • adhesives & sealants • paints & coatings • polymers • biotechnology • colourants & dyestuff s • food & drink • industrial cleaning • reprography & printing • water treatment and much more.


Organisers:


20 – 21 JUNE 2018 Koelnmesse


Cologne, Germany www.chemspeceurope.com


Drug Discovery World Winter 2017/18


67


Top conferences and workshops off er


valuable insights into ongoing R&D projects!


Agrochemical Lecture Theatre Chemspec Careers Clinic Pharma Lecture Theatre


Regulatory Services Lecture Theatre RSC Lecture Theatre Innovative Start-ups


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72